A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital

Clinical Microbiology and Infection

Volumn 12, Issue 6, 2006, Pages 527-532

  Blairon, L ^a   De Gheldre, Y ^a   Delaere, B ^a   Sonet, A ^a   Bosly, A ^a   Glupczynski, Youri ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Anaerobes; Bacteraemia; Co morbidities; Haematological malignancies; Neutropenia; Origin

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ANAEROBIC BACTERIUM; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTEROIDES FRAGILIS; BELGIUM; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL FEATURE; CLOSTRIDIUM; COMORBIDITY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FATALITY; FUSOBACTERIUM; GASTROINTESTINAL SURGERY; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; INTESTINE; LEPTOTRICHIA; MORTALITY; NONHUMAN; OROPHARYNX; PEPTOSTREPTOCOCCUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; CLOSTRIDIUM; FUSOBACTERIUM; LEPTOTRICHIA; PEPTOSTREPTOCOCCUS;

EID: 33646710092     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01407.x     Document Type: Article

References (20)

1. Lombardi DP, Engleberg NC. Anaerobic bacteremia: Incidence, patient characteristics, and clinical significance. Am J Med 1992; 92: 53-60.
2. Peraino VA, Cross SA, Goldstein EJ. Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis 1993; 16 (suppl 4): S288-S291.
3. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis 1996; 23 (suppl 1): S97 -S101.
4. Salonen JH, Eerola E, Meurman O. Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis 1998; 26: 1413-1417.
5. Dorsher CW, Rosenblatt JE, Wilson WR, Ilstrup DM. Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis 1991; 13: 633-636.
6. Chandler MT, Morton ES, Byrd RP, Fields C, Roy MT. Reevaluation of anaerobic blood cultures in a veteran population. South Med J 2000; 93: 896-898.
7. Ortiz E, Sande MA. Routine use of anaerobic blood cultures: Are they still indicated. Am J Med 2000; 108: 445-447.
8. Saito T, Senda K, Takakura S et al. Anaerobic bacteremia: The yield of positive anaerobic blood cultures: Patient characteristics and potential risk factors. Clin Chem Lab Med 2003; 41: 293-297.
9. Wilson JR, Limaye AP. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23: 310-316.
10. Noriega LM, Van der Auwera P, Phan M et al. Anaerobic bacteremia in a cancer center. Support Care Cancer 1993; 1: 250-255.
11. Gaynes RP, Horan TC. Surveillance of nosocomial infections. In: Mayhall CG, ed., Hospital epidemiology and infection control. Philadelphia, PA: Lipincott Williams & Wilkins, 1999; 1285-1317.
12. Citron DM. Algorithm for identification of anaerobic bacteria. In: Murray PR, Baron EJO, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology, 8th edn. Washington, DC: ASM Press, 2003; 343-344.
13. Comitéde l'antibiogramme de la SociétéFrançaise de Microbiologie. Communiqué2004. Paris: CASFM, 2004; 46.
14. Rosenblatt JE, Gustafson DR. Evaluation of the Etest for susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis 1995; 22: 279-284.
15. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th edn. Approved standard M11-A5. Wayne, PA: NCCLS, 2001.
16. Lark RL, McNeil SA, VanderHyde K, Noorani Z, Uberti J, Chenoweth C. Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 2001; 33: 338-343.
17. Spanik S, Trupl J, Kunova A et al. Bloodstream infections due to anaerobic bacteria in cancer patients: Epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia. Neoplasma 1996; 43: 235-238.
18. Lorber B. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium species (and other medically important anaerobic Gram-negative bacilli). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia, PA: Churchill Livingstone, 2000; 2561-2570.
19. Nguyen MH, Yu VL, Morris AJ et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: Findings of a multicenter prospective observational trial. Clin Infect Dis 2000; 30: 870-876.
20. Weinstein MP, Towns ML, Quartey SM et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.